ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 69 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 4.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $377,000 | -20.6% | 852,187 | -10.2% | 0.00% | 0.0% |
| Q4 2016 | $475,000 | -1.2% | 949,438 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $481,000 | +259.0% | 949,438 | +609.4% | 0.00% | +100.0% |
| Q2 2016 | $134,000 | -38.8% | 133,846 | -58.2% | 0.00% | 0.0% |
| Q1 2016 | $219,000 | +90.4% | 320,077 | +238.1% | 0.00% | 0.0% |
| Q4 2015 | $115,000 | +5650.0% | 94,662 | +16864.5% | 0.00% | – |
| Q2 2014 | $2,000 | -71.4% | 558 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | – | 558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 628,400 | $1,351,000 | 0.72% |
| BVF INC/IL | 1,368,500 | $2,942,000 | 0.62% |
| Abingworth LLP | 603,740 | $1,274,000 | 0.54% |
| Cheyne Capital Management (UK) LLP | 150,000 | $321,000 | 0.08% |
| THOMPSON DAVIS & CO., INC. | 26,488 | $57,000 | 0.07% |
| Telemetry Investments, L.L.C. | 50,000 | $108,000 | 0.06% |
| Nine Chapters Capital Management LLC | 96,400 | $207,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 51,512 | $111,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $187,000 | 0.01% |
| Tekla Capital Management LLC | 113,100 | $243,000 | 0.01% |